Empirical Finance’s Abiomed Inc ABMD Stock Holding History

Empirical Finance’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-974	Closed	-$239K	–	505
2022 Q3	$239K	Buy	+974	New	+$263K	0.03%	450
2022 Q2	–	Sell	-827	Closed	-$274K	–	508
2022 Q1	$274K	Buy	827 +93	+13%	+$28.6K	0.03%	427
2021 Q4	$264K	Buy	+734	New	+$248K	0.03%	425

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Empirical Finance's ABMD Position: Q4 2022 in Review

Empirical Finance sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 974 shares — an estimated $239K sold.

Empirical Finance first reported a position in ABMD in Q4 2021 and held it in 3 quarters. The position peaked at $274K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Empirical Finance reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Empirical Finance sold 974 Abiomed Inc shares in Q4 2022, an estimated $239K.
Empirical Finance first reported a position in Abiomed Inc in Q4 2021 and held it in 3 quarters.
Empirical Finance's Abiomed Inc position peaked at $274K in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Empirical Finance's 13F filing for Q4 2022, filed 24 Jan 2023.